EUVIMEDEUVIMED entdecken
Crossref

Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds

Rosa Furneaux

BMJ · 10.11.2026 · 395 · e101418

DOI: 10.1136/bmj-2026-101418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMJ, online erschienen am 10.11.2026. Verfasst von Rosa Furneaux. Beteiligte Einrichtung: The BMJ. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • The BMJ.

Zitieren

APA

Furneaux, R. (2026). Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds. BMJ, 395, e101418. https://doi.org/10.1136/bmj-2026-101418

Vancouver

Furneaux R. Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds. BMJ. 2026;395:e101418. doi:10.1136/bmj-2026-101418

BibTeX
@article{Furneaux2026,
  author = {Furneaux, Rosa},
  title = {Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds},
  journal = {BMJ},
  year = {2026},
  volume = {395},
  pages = {e101418},
  doi = {10.1136/bmj-2026-101418}
}
Kostenlos starten →